Nunatak Biotech Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
Nunatak Biotech General Information
Description
Developer of microbial symbiosis designed to manage crop performance under abiotic stress. The company's technology utilizes a proprietary library of genome-sequenced extremophile strains to develop microbial seed treatments and biological enhancers, providing agricultural producers with tools to increase yields and manage soil degradation through compatible biological inputs.
Contact Information
Website
www.nunatakbio.comCorporate Office
- Avenue Guillermo Udaondo 1003-1133
- C1428, C1429, Parque de Innovacion
- Buenos Aires, 1429
- Argentina
Corporate Office
- Avenue Guillermo Udaondo 1003-1133
- C1428, C1429, Parque de Innovacion
- Buenos Aires, 1429
- Argentina
Nunatak Biotech Timeline
Nunatak Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC | 01-Nov-2026 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 18-Jun-2025 | Completed | Product Development | |||
| 7. Accelerator/Incubator | Completed | Product Development | ||||
| 6. Accelerator/Incubator | 11-Dec-2024 | Completed | Product Development | |||
| 5. Accelerator/Incubator | 04-Dec-2024 | Completed | Product Development | |||
| 4. Angel (individual) | 29-Nov-2024 | Completed | Product Development | |||
| 3. Accelerator/Incubator | 11-Sep-2024 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 07-Mar-2024 | Completed | Product Development | |||
| 1. Grant | 03-Oct-2023 | $500K | Completed | Product Development |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nunatak Biotech Comparisons
Industry
Financing
Details
Nunatak Biotech Competitors (1)
One of Nunatak Biotech’s competitors is Puna Bio, a Venture Capital-Backed company based in Buenos Aires, Argentina.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Puna Bio | Venture Capital-Backed | Buenos Aires, Argentina |
Nunatak Biotech Signals
Nunatak Biotech Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innventure AgriFood Tech | Venture Capital | Minority | ||
| Eatable Adventures | Accelerator/Incubator | |||
| YECO Accelerator | Accelerator/Incubator | |||
| Grid Exponential | Accelerator/Incubator | Minority | ||
| Thrive AgriFood | Accelerator/Incubator |
Nunatak Biotech FAQs
-
When was Nunatak Biotech founded?
Nunatak Biotech was founded in 2023.
-
Where is Nunatak Biotech headquartered?
Nunatak Biotech is headquartered in Buenos Aires, Argentina.
-
What is the size of Nunatak Biotech?
Nunatak Biotech has 6 total employees.
-
What industry is Nunatak Biotech in?
Nunatak Biotech’s primary industry is Other Agriculture.
-
Is Nunatak Biotech a private or public company?
Nunatak Biotech is a Private company.
-
What is Nunatak Biotech’s current revenue?
The current revenue for Nunatak Biotech is .
-
How much funding has Nunatak Biotech raised over time?
Nunatak Biotech has raised $275K.
-
Who are Nunatak Biotech’s investors?
Innventure AgriFood Tech, Eatable Adventures, YECO Accelerator, Grid Exponential, and Thrive AgriFood are 5 of 8 investors who have invested in Nunatak Biotech.
-
Who are Nunatak Biotech’s competitors?
Puna Bio is a competitor of Nunatak Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process